The Hepatitis C Virus Treatment Revolution-Can the Developing World Afford it?

Syed Amer, Amtul Hajira, Mohammed Muqeetadnan


Hepatitis C is the leading cause of hepatocellular carcinoma worldwide. Recently, several new, highly effective directly acting antivirals have entered the introduced in the market. But the high cost of these medications prohibits the widespread use in the developing world. We, through our paper would like to suggest steps towards making these medications widely available to the population that needs them the most.


Hepatitis C; Directly acting antivirals; Developing world

Full Text: PDF HTML


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.